MX3428E - PROCEDURE FOR THE PREPARATION OF (AROIL-2 'ET-1'IL) -1 (ACETAMIDO-4 "PIPERAZIN-1" IL METHYL) -2 BENZIMIDAZOLES - Google Patents
PROCEDURE FOR THE PREPARATION OF (AROIL-2 'ET-1'IL) -1 (ACETAMIDO-4 "PIPERAZIN-1" IL METHYL) -2 BENZIMIDAZOLESInfo
- Publication number
- MX3428E MX3428E MX001645U MX164576U MX3428E MX 3428 E MX3428 E MX 3428E MX 001645 U MX001645 U MX 001645U MX 164576 U MX164576 U MX 164576U MX 3428 E MX3428 E MX 3428E
- Authority
- MX
- Mexico
- Prior art keywords
- group
- carbon atoms
- formula
- alkyl group
- see
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/10—Radicals substituted by halogen atoms or nitro radicals
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
La presente invención se refiere a un procedimiento para la preparación de (aroil-2' et-1'i1)-1 (acetamido-4" piperazin-1"il metil)-2 benzimidazoles que corresponden a la fórmula (I): (ver figura). Ar designa: un núcleo fenilo eventualmente substituído por un grupo alcoxi que comprende a lo sumo cuatro átomos de carbono, por un grupo alquilo que comprende a lo sumo 4 átomos de carbono, por un grupo alquilo que comprende de 1 a 4 átomos de carbono, por un grupo nitro o por un átomo halógeno, o un radical alfa-furilo o alfa-tienilo, R designa: un agrupamiento -NH2, un agrupamiento -NHR' en donde R1 representa un grupo alquilo que comprende de 1 a 4 átomos de carbono, o un grupo cicloalquilo que comprende a lo sumo 6 átomos de carbono, o un agrupamiento -NR1R2 en donde R1 y R2 designan un grupo alquilo que comprende de 1 a 4 átomos de carbono o forman, junto con el átomo de nitrógeno al cual se enlazan, heterocíclico elegidos estre las siguientes: piridino, pirrolidino, morfolino y hexametilenoimino, caracterizado porque consiste en condensar un compuesto de la fórmula (II): (ver figura). en donde Ar tiene el mismo significado que la fórmula (I), con una piperazina de la fórmula (III): (ver figura). En la cual R tiene el mismo significado que en la fórmula (I), a reflujo en un disolvente orgánico tal como acetato de etilo en presencia de una base como el carbonato de sodio.The present invention relates to a process for the preparation of (aroyl-2 'et-1'i1) -1 (acetamido-4 "piperazin-1" yl methyl) -2 benzimidazoles corresponding to formula (I): ( see Figure). Ar designates: a phenyl nucleus possibly substituted by an alkoxy group comprising at most four carbon atoms, by an alkyl group comprising at most 4 carbon atoms, by an alkyl group comprising from 1 to 4 carbon atoms, by a nitro group or by a halogen atom, or an alpha-furyl or alpha-thienyl radical, R designates: a -NH2 group, a -NHR 'group where R1 represents an alkyl group comprising 1 to 4 carbon atoms , or a cycloalkyl group comprising at most 6 carbon atoms, or a group -NR1R2 where R1 and R2 designate an alkyl group comprising 1 to 4 carbon atoms or together with the nitrogen atom to which they are formed They link, chosen heterocyclic with the following: pyridine, pyrrolidine, morpholino and hexamethyleneimino, characterized in that it consists of condensing a compound of formula (II): (see figure). where Ar has the same meaning as formula (I), with a piperazine of formula (III): (see figure). In which R has the same meaning as in formula (I), at reflux in an organic solvent such as ethyl acetate in the presence of a base such as sodium carbonate.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR7500724A FR2297045A1 (en) | 1975-01-10 | 1975-01-10 | NEW (AROYL-2 'ETH-1' YL) -1 (ACETAMIDO-4 '' PIPERAZIN-1 '' YL METHYL) -2 BENZIMIDAZOLES WITH GASTRIC AND ANTIULCEROUS ANTI-SECRETORY PROPERTIES |
FR7537297A FR2333510A2 (en) | 1975-12-05 | 1975-12-05 | 1-Aroylethyl 2-piperazinomethyl benzimidazoles - useful eg for treatment of ulcers, asthma, hypertension, oedemand pain |
Publications (1)
Publication Number | Publication Date |
---|---|
MX3428E true MX3428E (en) | 1980-11-21 |
Family
ID=26218682
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX001645U MX3428E (en) | 1975-01-10 | 1976-01-06 | PROCEDURE FOR THE PREPARATION OF (AROIL-2 'ET-1'IL) -1 (ACETAMIDO-4 "PIPERAZIN-1" IL METHYL) -2 BENZIMIDAZOLES |
Country Status (13)
Country | Link |
---|---|
JP (1) | JPS6020386B2 (en) |
AU (1) | AU509084B2 (en) |
CA (1) | CA1073455A (en) |
CH (1) | CH612675A5 (en) |
DE (1) | DE2557446C2 (en) |
ES (1) | ES444064A1 (en) |
GB (1) | GB1487128A (en) |
IT (1) | IT1062803B (en) |
LU (1) | LU74043A1 (en) |
MX (1) | MX3428E (en) |
NL (1) | NL7600224A (en) |
SE (1) | SE421527B (en) |
SU (1) | SU651701A3 (en) |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2190439B1 (en) * | 1972-07-06 | 1975-06-20 | Delalande Sa |
-
1975
- 1975-12-16 GB GB51396/75A patent/GB1487128A/en not_active Expired
- 1975-12-18 LU LU74043A patent/LU74043A1/xx unknown
- 1975-12-19 DE DE2557446A patent/DE2557446C2/en not_active Expired
-
1976
- 1976-01-03 ES ES444064A patent/ES444064A1/en not_active Expired
- 1976-01-06 MX MX001645U patent/MX3428E/en unknown
- 1976-01-07 CH CH12876A patent/CH612675A5/en not_active IP Right Cessation
- 1976-01-08 SE SE7600116A patent/SE421527B/en unknown
- 1976-01-08 SU SU762305959A patent/SU651701A3/en active
- 1976-01-08 CA CA243,226A patent/CA1073455A/en not_active Expired
- 1976-01-08 JP JP761833A patent/JPS6020386B2/en not_active Expired
- 1976-01-08 AU AU10117/76A patent/AU509084B2/en not_active Expired
- 1976-01-09 NL NL7600224A patent/NL7600224A/en not_active Application Discontinuation
- 1976-01-09 IT IT67044/76A patent/IT1062803B/en active
Also Published As
Publication number | Publication date |
---|---|
ES444064A1 (en) | 1977-08-16 |
IT1062803B (en) | 1985-02-11 |
JPS6020386B2 (en) | 1985-05-21 |
JPS51131885A (en) | 1976-11-16 |
SE421527B (en) | 1982-01-04 |
SE7600116L (en) | 1976-07-12 |
LU74043A1 (en) | 1976-11-11 |
CA1073455A (en) | 1980-03-11 |
AU509084B2 (en) | 1980-04-17 |
AU1011776A (en) | 1977-07-14 |
GB1487128A (en) | 1977-09-28 |
DE2557446C2 (en) | 1984-11-29 |
SU651701A3 (en) | 1979-03-05 |
CH612675A5 (en) | 1979-08-15 |
NL7600224A (en) | 1976-07-13 |
DE2557446A1 (en) | 1976-07-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2221440T3 (en) | AMINOPHENOXYACETIC ACID DERIVATIVES AS NEUROPROTECTORS. | |
ES302622A1 (en) | Procedure for the preparation of heterociclic derivatives. (Machine-translation by Google Translate, not legally binding) | |
ES395714A1 (en) | Pyridoquinoline dicarboxylic acid derivatives | |
GB1014053A (en) | 7-hydroxy-coumarin derivatives and process for their production | |
ES8503346A1 (en) | Alkanoylanilides. | |
ES298057A1 (en) | Procedure for the preparation of new nitrogen bases (Machine-translation by Google Translate, not legally binding) | |
ES434512A2 (en) | Substituted piperidine derivatives | |
ES387016A1 (en) | Isoquinoline derivatives | |
MX3428E (en) | PROCEDURE FOR THE PREPARATION OF (AROIL-2 'ET-1'IL) -1 (ACETAMIDO-4 "PIPERAZIN-1" IL METHYL) -2 BENZIMIDAZOLES | |
GB917078A (en) | Improvements in or relating to piperidine derivatives | |
ES448594A1 (en) | Diarylbutanolamines | |
GB1008849A (en) | Basically substituted triazolidines, processes for their manufacture and pharmaceutical preparations containing them | |
ES394972A1 (en) | 3-lower alkyl-5-(o-(omega-amino-alkoxy)-phenoxymethyl)-isoxazoles and salts thereof | |
KR910007939A (en) | Heterocyclic Compounds and Methods for Making the Same | |
GB1114694A (en) | Diazaspiro[4,5]decan-1,3-dione derivatives | |
ES453121A1 (en) | Substituted aminoalkylaminopyridine compounds | |
ES362369A1 (en) | Isonipecotic acid derivatives | |
ES454285A1 (en) | 4-amino-trans-decahydroquinoline derivatives | |
ES446090A1 (en) | Procedure for the obtaining of derivatives of tetrahidropiridina and piperidina. (Machine-translation by Google Translate, not legally binding) | |
GB815968A (en) | New dioxolane derivatives and process for their preparation | |
ES327879A1 (en) | A procedure for the obtaining of new i-cicloalcohiledenetil-4-fenil-piperidinas. (Machine-translation by Google Translate, not legally binding) | |
GB1037894A (en) | New isourea derivatives and process for the production thereof | |
SE7606592L (en) | NEW AMINOBENZOIC ACID DERIVATIVES, PROCEDURES FOR PRODUCING THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE | |
GB1067626A (en) | 3-aminoalkyl-4-alkyl-coumarin derivatives and process for the manufacture thereof | |
MX3286E (en) | PROCEDURE TO PREPARE OXIME ETERS |